| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Removal from Official List
|
20 Aug 2025 10:45AM |
$0.045 |
$0.045 |
fallen by
0%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Ceasing to be a Substantial Holder
|
20 Aug 2025 10:18AM |
$0.045 |
$0.045 |
fallen by
0%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Notice of Ceasing to be a Substantial Shareholder
|
20 Aug 2025 10:09AM |
$0.045 |
$0.045 |
fallen by
0%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Implementation of Scheme
|
19 Aug 2025 2:29PM |
$0.045 |
$0.045 |
fallen by
0%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Ceasing to be a substantial holder
|
14 Aug 2025 1:14PM |
$0.045 |
$0.045 |
fallen by
0%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Suspension from Quotation
|
8 Aug 2025 7:01PM |
$0.045 |
$0.045 |
fallen by
0%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Donaco International Limited (DNA) requested voluntary suspension from quotation on the ASX.
- The suspension is related to an impending announcement about a significant operational matter.
- The company expects to make the relevant announcement by 17 June 2024.
- The voluntary suspension follows a previous trading halt.
- The suspension is intended to ensure the market is fully informed.
- Donaco International Limited is coordinating with the ASX to resolve the issue.
- An update will be provided to the market as soon as possible.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Becoming a substantial holder
|
8 Aug 2025 4:36PM |
$0.045 |
$0.045 |
fallen by
0%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Scheme Becomes Effective
|
8 Aug 2025 12:37PM |
$0.044 |
$0.045 |
risen by
2.27%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- The scheme of arrangement for Donaco International Limited has become effective.
- Supreme Court of New South Wales and ASIC have granted approvals.
- DNA Investments Holdings Pty Ltd will acquire all shares in Donaco International Limited.
- Donaco shares will be suspended from ASX at the close of trading on 21 June 2024.
- Scheme record date is 25 June 2024 and implementation is expected on 28 June 2024.
- Shareholders are given contact information for further queries.
- Legal and regulatory processes necessary for the scheme’s effectiveness have been completed.
- The company secretary authorized the announcement on 20 June 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Court Approves Scheme
|
7 Aug 2025 12:45PM |
$0.045 |
$0.045 |
risen by
1.12%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Supreme Court of New South Wales approved the scheme of arrangement for Donaco International Limited.
- DNA Bidco Pty Ltd will acquire all shares in Donaco International Limited under the scheme.
- Scheme approved by Donaco shareholders on 31 May 2024.
- Court orders lodged with the Australian Securities and Investments Commission make the scheme legally effective.
- Trading in Donaco shares on the ASX will be suspended from close of trading on 6 June 2024.
- Scheme implementation date is expected to be 14 June 2024.
- Eligible Donaco shareholders will receive the scheme consideration on the implementation date.
- Further updates will be provided as necessary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Results of Scheme Meeting
|
4 Aug 2025 12:43PM |
$0.044 |
$0.045 |
risen by
2.27%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Donaco International Limited held a Scheme Meeting to consider the acquisition by DNA Holdings Pty Ltd.
- The Scheme Meeting was convened in accordance with orders from the Supreme Court of New South Wales.
- Shareholders were provided with a Scheme Booklet outlining the details and effects of the scheme.
- The requisite majorities of shareholders voted in favor of the scheme: over 50% by number and at least 75% by value.
- The results will be reported to the court for final approval at the Second Court Hearing.
- If approved by the court, the scheme will become legally effective and implemented according to the timetable.
- Shareholders who did not vote in favor may have rights to object at the Second Court Hearing.
- Trading in Donaco shares will continue until the scheme becomes effective or is discontinued.
- Further announcements will be made to update shareholders on subsequent steps and outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Scheme Meeting Chairman's Address and Presentation
|
4 Aug 2025 8:25AM |
$0.044 |
$0.045 |
risen by
2.27%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Donaco International Limited is subject to a proposed scheme of arrangement with DNA BidCo Pty Ltd, owned by OCP Asia.
- The Board unanimously recommends shareholders vote in favour of the scheme, in absence of a superior proposal.
- The independent expert considers the scheme fair and reasonable, and in the best interests of shareholders.
- The offer provides a cash consideration for each DNA share, with details specified in the scheme booklet.
- The Scheme Meeting is being held to allow eligible shareholders to vote on the proposed scheme.
- A strategic review was undertaken prior to entering into the scheme implementation deed.
- The Chairman explains the rationale for the scheme, including market conditions and strategic alternatives considered.
- Details about the voting procedure, eligibility, and timetable for implementation are provided.
- The presentation includes a summary of the key terms of the scheme, the expected timeline, and the process if the scheme is not approved.
- Shareholders are urged to carefully consider the scheme and participate in the voting process.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Quarterly Activities and Cashflow Reports
|
30 Jul 2025 8:30AM |
$0.043 |
$0.045 |
risen by
4.65%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarter ended 31 March 2023 saw strong trading momentum due to recovery from COVID-19 impacts.
- Improved performance in both Star Vegas (Cambodia) and Aristo International Hotel (Vietnam) as borders reopened.
- EBITDA for the quarter rose to $5.2 million, an increase from the previous corresponding period.
- Continued focus on cost control and operational efficiency.
- Positive operating cash flow of $4.6 million and cash reserves increased to $18.7 million.
- No debt as of 31 March 2023.
- The company is maintaining operational discipline and monitoring the regional tourism environment.
- Management is reviewing its strategy and exploring opportunities for further growth as travel rebounds.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Dispatch of Scheme Booklet
|
1 Jul 2025 8:28AM |
$0.042 |
$0.045 |
risen by
7.14%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Scheme Booklet Registered with ASIC
|
23 Jun 2025 2:39PM |
$0.041 |
$0.045 |
risen by
9.76%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Court Approves Convening of Scheme Meeting
|
20 Jun 2025 5:21PM |
$0.040 |
$0.045 |
risen by
12.50%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- The Federal Court of Australia has approved convening a Scheme Meeting for Donaco shareholders.
- The Scheme involves the acquisition of all issued shares in Donaco by OL Master Limited (OCP Asia).
- If approved, Donaco will become a wholly-owned subsidiary of OCP Asia.
- The Scheme Meeting will be held on 7 July 2022.
- Donaco's Board unanimously recommends shareholders vote in favor of the Scheme, subject to no superior proposal and a positive Independent Expert report.
- An Independent Expert will provide a report on whether the Scheme is in shareholders' best interests.
- The document provides instructions for participating and voting at the Scheme Meeting.
- The rationale, advantages, and implications of the scheme for shareholders are outlined.
- Background on the transaction and next steps if the Scheme is approved are discussed.
- Key dates and the process for implementation are provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Impact of Thailand Border Restrictions on DSV Operations
|
16 Jun 2025 5:11PM |
$0.041 |
$0.045 |
risen by
9.76%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Updated Indicative Scheme Timetable
|
5 Jun 2025 9:38AM |
$0.038 |
$0.045 |
risen by
18.42%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Update on Scheme Timetable and Cambodian Gaming Tax Position
|
9 May 2025 9:38AM |
$0.044 |
$0.045 |
risen by
3.45%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Update provided on the scheme of arrangement timetable for Donaco International Limited.
- The scheduled dates for the scheme have been adjusted due to administrative or regulatory reasons.
- There is a detailed explanation of the changes to the scheme timetable.
- The announcement includes a clarification on the company's current Cambodian gaming tax position.
- Donaco addresses recent developments with respect to its tax obligations in Cambodia.
- The update seeks to keep shareholders and stakeholders informed about regulatory and taxation matters impacting the company.
- The company reaffirms its commitment to compliance with relevant regulatory and taxation requirements.
- The announcement provides guidance for shareholders regarding the next steps and anticipated future updates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Quarterly Activities and Cashflow Reports
|
29 Apr 2025 9:04AM |
$0.042 |
$0.045 |
risen by
7.14%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Cashflow Reports cover the period ending 31 March 2024.
- Revenue and EBITDA increased compared to the previous quarter.
- Improvements driven by recovery at Star Vegas and Aristo casinos.
- International tourism growth contributed to operational recovery.
- Cost control and operational efficiencies remain a focus.
- Strong cash balance maintained throughout the quarter.
- Includes regulatory, compliance updates, and management commentary.
- Company continues to pursue strategies for sustainable growth.
- Detailed cash flow analysis presented.
- No material changes in business structure or major new projects reported for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Appointment of Joint Company Secretary
|
21 Mar 2025 8:25AM |
$0.042 |
$0.045 |
risen by
7.14%
|
|
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
DNA enters Scheme Implementation Deed
|
17 Mar 2025 9:04AM |
$0.030 |
$0.045 |
risen by
50%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Donaco enters into a Scheme Implementation Deed with On Nut Road Limited.
- The acquisition price is set at A$0.045 cash per share.
- The offer represents a premium of 50% to the closing price prior to the announcement.
- The Board recommends shareholders vote in favor of the Scheme.
- Key shareholders indicated support for the Scheme.
- Implementation is expected by June 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
1H FY25 Results Summary
|
28 Feb 2025 8:56AM |
$0.030 |
$0.045 |
risen by
50%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Group net revenue of A$21.83 million represents a 12.2% increase compared to 1H FY24.
- EBITDA increased by 17.0% to A$11.39 million.
- Net profit after tax rose to A$7.77 million, a 36.3% increase from the previous year.
- DNA Star Vegas reported net revenue of A$14.08 million with an EBITDA of A$8.10 million.
- Aristo International Hotel's revenue increased by 27.3% to A$7.76 million, with EBITDA up 39.9%.
- The company had a strong cash position of A$36.26 million as of 31 December 2024.
- Donaco faces regulatory challenges in Thailand which may impact operations.
- Legal proceedings related to tax issues in Vietnam are ongoing, with potential financial implications.
- The company remains optimistic about future growth opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Appendix 4D and Half Year Financial Report
|
28 Feb 2025 8:49AM |
$0.030 |
$0.045 |
risen by
50%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit for half-year ended 31 December 2024 was $7,769,143.
- Profit increased from $5,701,993 in the previous year.
- Donaco operates hotels and casinos in Vietnam and Cambodia.
- The report includes financial performance details.
- Directors express confidence in meeting financial obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Quarterly Activities and Cashflow Reports
|
31 Jan 2025 8:21AM |
$0.030 |
$0.045 |
risen by
50%
|
|
DNA - Price-sensitive ASX Announcement
Full Release
Key Points
- Donaco reported group net revenue of A$10.30 million for the December Quarter.
- EBITDA increased to A$5.77 million compared to the previous quarter.
- Star Vegas achieved net revenue of A$6.57 million, an increase from the previous quarter.
- Aristo International Hotel recorded steady revenue of A$3.73 million.
- Cash position rose to A$36.26 million, a 10% increase from the previous quarter.
- The company is actively monitoring developments in Southeast Asia's gaming industry.
- Donaco's membership loyalty program has driven increased visitation over the past year.
- The Thai Cabinet approved the Draft Entertainment Complex Business Act in principle.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Donaco International Limited (DNA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Results of Meeting
|
22 Nov 2024 4:32PM |
$0.027 |
$0.045 |
risen by
66.67%
|
|
Call 1300 880 160
Start a chat
Schedule a call
